Live Streaming
Program Highlight
Company Profile
Zona Integritas
Friday, 04 February 2022 15:35

Novavax's COVID-19 shot receives provisional approval in New Zealand

Written by 
Rate this item
(0 votes)

52OWY3EOQBPZZJPRWYYGAQHNIE.jpg

Novavax Inc (NVAX.O) said on Thursday it had received provisional approval from New Zealand's medicines regulator for its COVID-19 vaccine, Nuvaxovid, for individuals 18 years of age and older. (Reuters)

Read 324 times
Published in International News
Nur Yasmin

Latest from Nur Yasmin

More in this category: « Hong Kong expands government work-from-home plans as Omicron bites Japan has no plans to review sales tax rates, finance minister says »
back to top